Category one submissions will be for medicines considered to have significant "added therapeutic value" - this categorisation system negotiated with the industry explicitly and objectively prioritises the needs of some patients over others. …
Latest Video
New Stories
-
Pharmaxis reports new positive results for LOXL2 program
November 16, 2018 - - Latest News -
Government extends CSO contracts and links outcome to SPA changes
November 16, 2018 - - Latest News -
Industry executive to lead Anatara
November 16, 2018 - - Latest News -
Novartis confirms Alcon spinoff details
November 16, 2018 - - Latest News -
Industry looks for protections on pathway reforms
November 15, 2018 - - Latest News -
MPA meets for regular catch-up
November 15, 2018 - - Latest News -
Government extends My Health Record opt-out period
November 15, 2018 - - Latest News